Wird geladen...

Metabolic Tumor Volume is an Independent Prognostic Factor in Patients Treated Definitively for Non–Small-Cell Lung Cancer

Fluroine-18 flurodeoxyglucose positron emission tomography (FDG-PET) imaging is considered standard for Non-Small Cell Lung Cancer (NSCLC). A retrospective review of 61 patients with NSCLC showed that higher FDG-PET metabolic tumor volume portended worse outcomes overall and in a subset of patients...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clin Lung Cancer
Hauptverfasser:	Lee, Percy, Bazan, Jose G., Lavori, Philip W., Weerasuriya, Dilani K., Quon, Andrew, Le, Quynh-Thu, Wakelee, Heather A., Graves, Edward E., Loo, Billy W.
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	2011
Schlagworte:	Article
Online Zugang:	https://ncbi.nlm.nih.gov/pmc/articles/PMC4296977/ https://ncbi.nlm.nih.gov/pubmed/21703935 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cllc.2011.05.001
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Metabolic Tumor Volume is an Independent Prognostic Factor in Patients Treated Definitively for Non–Small-Cell Lung Cancer

Ähnliche Einträge